Diagnosing iron deficiency anemia (IDA) in hospitalized patients often proves difficult. Traditional markers like serum ferritin fluctuate during acute illness, leading to diagnostic confusion. Recently, researchers evaluated the utility of Ret-He for anemia diagnosis in acutely ill children to address this clinical gap. This marker represents the hemoglobin content in young red blood cells and provides a real-time view of iron availability.

Why Use Ret-He for Anemia Diagnosis in Acute Illness?

During infection or inflammation, the body produces acute-phase reactants. Serum ferritin is one such reactant, often appearing falsely elevated even when a patient lacks sufficient iron. Consequently, clinicians may miss cases of IDA in sick children. However, Reticulocyte Hemoglobin Equivalent (Ret-He) remains largely unaffected by these inflammatory shifts. Notably, the study found that Ret-He levels were significantly lower in children with IDA compared to normal or non-anemic iron-deficient groups. This stability makes it an invaluable tool for pediatricians managing acutely ill patients.

Clinical Performance and Diagnostic Cut-offs

The research established a specific Ret-He cut-off of 23.95 pg for identifying iron deficiency anemia. At this level, the marker demonstrated a sensitivity of 78.4% and a specificity of 81.0%. In comparison, traditional serum ferritin tests showed much lower sensitivity, identifying only 23.5% of cases at standard thresholds. Furthermore, Ret-He displayed a stronger correlation with established surrogate standards for anemia than ferritin did. Therefore, incorporating Ret-He into routine hematological panels could significantly improve diagnostic accuracy and speed up treatment decisions in hospital settings.

Summary of Key Findings

Specifically, the study analyzed 246 children and found that the IDA group had lower Ret-He levels (mean 18.25 pg) than the normal group (mean 28.5 pg). Additionally, the area under the ROC curve (AUC) for Ret-He was 0.865, indicating high diagnostic performance. By using this parameter, doctors can bypass the diagnostic interference of the acute phase response. This ensures that children receive timely iron supplementation, which is critical for their overall recovery and long-term development.

FAQs

How does Ret-He differ from serum ferritin?

Unlike serum ferritin, which is an acute-phase reactant that increases during inflammation, Ret-He reflects the iron available for red blood cell production over the last 48 to 72 hours and is not influenced by inflammatory states.

What is the recommended Ret-He cut-off for pediatric IDA?

Recent studies suggest a Ret-He cut-off of 23.95 pg as an effective threshold for diagnosing iron deficiency anemia in acutely ill hospitalized children.

Can Ret-He be used for screening in outpatient settings?

Yes, Ret-He is a rapid and cost-effective parameter available on many modern hematology analyzers, making it suitable for both inpatient diagnosis and outpatient screening.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.

References

1. Otiv MS et al. Reticulocyte Hemoglobin Equivalent (Ret-He) as a Marker of Iron Deficiency Anemia in Acutely Ill Hospitalized Children. Indian J Pediatr. 2026 Jun 19. doi: 10.1007/s12098-026-06195-9. PMID: 42319743.


2. Auerbach M, Adamson JW. How we diagnose and treat iron deficiency anemia. Am J Hematol. 2016;91(1):31-38.


3. David O. Reticulocyte hemoglobin equivalent (Ret-He): a useful marker in the diagnosis of iron deficiency. Clin Chem Lab Med. 2006;44(11):1341-5.